Duff; Karen

Patent Applications and Registrations

Patent applications and USPTO patent grants for Duff; Karen.The latest application filed is for "activators of autophagic flux and phospholipase d and clearance of protein aggregates including tau and treatment of proteinopat".

Company Profile

6.6.10

Duff; Karen - New York NY
- New York NY US
Duff, Karen - Village Apt. 6J NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Activators of autophagic flux and phospholipase d and clearance of protein aggregates including tau and treatment of proteinopathies Grant 11,261,199 - Rinderspacher , et al. March 1, 2	2022-03-01
Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathies Grant 11,230,558 - Rinderspacher , et al. January 25, 2	2022-01-25
Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathies Grant 11,008,341 - Rinderspacher , et al. May 18, 2	2021-05-18
Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathies Grant 10,865,214 - Rinderspacher , et al. December 15, 2	2020-12-15
Activators Of Autophagic Flux And Phospholipase D And Clearance Of Protein Aggregates Including Tau And Treatment Of Proteinopat App 20200216469 - Rinderspacher; Kirsten Alison ; et al.	2020-07-09
Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathies Grant 10626124 -	2020-04-21
Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathies Grant 10,487,091 - Rinderspacher , et al. Nov	2019-11-26
Activators Of Autophagic Flux And Phospholipase D And Clearance Of Protein Aggregates Including Tau And Treatment Of Proteinopathies App 20190112317 - Rinderspacher; Kirsten Alison ; et al.	2019-04-18
Activators Of Autophagic Flux And Phospholipase D And Clearance Of Protein Aggregates Including Tau And Treatment Of Proteinopathies App 20180319818 - Rinderspacher; Kirsten Alison ; et al.	2018-11-08
Activators Of Autophagic Flux And Phospholipase D And Clearance Of Protein Aggregates Including Tau And Treatment Of Proteinopathies App 20180312526 - Rinderspacher; Kirsten Alison ; et al.	2018-11-01
Activators Of Autophagic Flux And Phospholipase D And Clearance Of Protein Aggregates Including Tau And Treatment Of Proteinopathies App 20180312527 - Rinderspacher; Kirsten Alison ; et al.	2018-11-01
Activators Of Autophagic Flux And Phospholipase D And Clearance Of Protein Aggregates Including Tau And Treatment Of Proteinopathies App 20170210759 - Rinderspacher; Kirsten Alison ; et al.	2017-07-27
Transgenic Mice Comprising A Genomic Human Tau Transgene App 20070118915 - Duff; Karen ; et al.	2007-05-24
Transgenic mice comprising a genomic human tau transgene Grant 7,161,060 - Duff , et al. January 9, 2	2007-01-09
Sequestration of ass in the periphery in the absence of immunomodulating agent as a therapeutic approach for the treatment or prevention of beta-amyloid related diseases App 20050227941 - Duff, Karen ; et al.	2005-10-13
Method for producing transgenic animal models with modulated phenotype and animals produced therefrom App 20030131364 - Duff, Karen	2003-07-10
Transgenic mice comprising a genomic human tau transgene App 20030115621 - Duff, Karen	2003-06-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.